Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Eris Lifesciences Limited
  6. Financials
    540596   INE406M01024

ERIS LIFESCIENCES LIMITED

(540596)
  Report
End-of-day quote Bombay Stock Exchange  -  2022-10-03
740.05 INR   +1.17%
09/09Eris Lifesciences : ESOP/ESPS/SBEB Scheme
PU
08/25Eris Lifesciences Seeks Acquisitions
CI
08/05Eris Lifesciences Limited Provides Revenue Guidance for the Year 2023
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: March 2020 2021 2022 2023 2024 2025
Capitalization1 50 03582 07393 669100 640--
Enterprise Value (EV)1 50 03582 07393 669104 854101 49797 349
P/E ratio 17,1x23,1x23,1x23,9x19,5x19,4x
Yield 0,62%0,91%-0,92%1,06%1,10%
Capitalization / Revenue 4,66x6,77x6,95x5,83x5,06x4,40x
EV / Revenue 4,66x6,77x6,95x6,07x5,11x4,26x
EV / EBITDA 13,6x19,1x19,3x18,6x15,1x12,3x
Price to Book 3,86x5,21x4,91x4,50x3,85x3,19x
Nbr of stocks (in thousands) 135 781135 781135 930135 991--
Reference price (INR) 369604689740740740
Announcement Date 06/02/202005/13/202105/03/2022---
1 INR in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: March 2020 2021 2022 2023 2024 2025
Net sales1 10 74112 11913 47017 27619 87122 877
EBITDA1 3 6834 3064 8505 6526 7037 888
Operating profit (EBIT)1 3 1803 8764 2034 6805 7226 723
Operating Margin 29,6%32,0%31,2%27,1%28,8%29,4%
Pre-Tax Profit (EBT)1 3 3153 9454 4224 7185 8336 630
Net income1 2 9633 5514 0614 2135 1655 195
Net margin 27,6%29,3%30,1%24,4%26,0%22,7%
EPS2 21,626,129,931,037,938,2
Dividend per Share2 2,295,50-6,817,888,11
Announcement Date 06/02/202005/13/202105/03/2022---
1 INR in Million
2 INR
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: March 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales1 3 5973 3223 0593 9864 3524 384
EBITDA1 1 3981 2179691 2921 3581 499
Operating profit (EBIT) ------
Operating Margin ------
Pre-Tax Profit (EBT)1 1 3081 0908531 0131 0941 249
Net income1 1 1841 0088039469901 131
Net margin 32,9%30,3%26,2%23,7%22,7%25,8%
EPS ------
Dividend per Share ------
Announcement Date 10/29/202101/28/202205/03/202208/05/2022--
1 INR in Million
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: March 2020 2021 2022 2023 2024 2025
Net Debt1 ---4 214857-
Net Cash position1 -----3 291
Leverage (Debt / EBITDA) ---0,75x0,13x-0,42x
Free Cash Flow1 1 1983 4962 572-3 0164 2215 626
ROE (Net Profit / Equities) 24,2%24,7%23,3%20,7%21,4%18,5%
Shareholders' equity1 12 23314 36417 42420 37524 08728 041
ROA (Net Profit / Asset) 19,1%-----
Assets1 15 535-----
Book Value Per Share2 95,5116140164192232
Cash Flow per Share2 -27,627,839,145,847,3
Capex1 1 5132581 2107 318851450
Capex / Sales 14,1%2,13%8,99%42,4%4,28%1,97%
Announcement Date 06/02/202005/13/202105/03/2022---
1 INR in Million
2 INR
Previous periodNext period
Estimates
Key data
Capitalization (INR) 100 639 930 115
Capitalization (USD) 1 236 736 534
Net sales (INR) 13 470 430 000
Net sales (USD) 165 534 424
Number of employees 3 400
Sales / Employee (INR) 3 961 891
Sales / Employee (USD) 48 687
Free-Float 21,5%
Free-Float capitalization (INR) 21 680 197 679
Free-Float capitalization (USD) 266 422 011
Avg. Exchange 20 sessions (INR) 3 010 523
Avg. Exchange 20 sessions (USD) 36 995
Average Daily Capital Traded 0,00%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA